1. Home
  2. KA

KA

Kineta Inc.

Logo Kineta Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.

Founded: 2007 Country:
United States
United States
Employees: N/A City: MERCER ISLAND
Market Cap: 4.0M IPO Year: N/A
Target Price: $8.00 AVG Volume (30 days): 347.5K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.28 EPS Growth: N/A
52 Week Low/High: $0.35 - $5.39 Next Earning Date: 05-09-2024
Revenue: $5,442,000 Revenue Growth: 178.65%
Revenue Growth (this year): -88.64% Revenue Growth (next year): N/A

Share on Social Networks: